---
figid: PMC6270990__er.2018-00006f2
figtitle: PD-1 action on T-cells
organisms:
- Homo sapiens
pmcid: PMC6270990
filename: er.2018-00006f2.jpg
figlink: pmc/articles/PMC6270990/figure/F2/
number: F2
caption: Mechanisms of PD-1 action on T-cells. Engagement of PD-1 with its ligand
  PD-L1 induces an intracellular inhibitory pathway to inhibit costimulatory CD28-activated
  PI3K pathways. As a result, gluconeogenesis and glucose uptake decrease, leading
  to T-cell exhaustion. Bcl-xL, B-cell lymphoma-extra large; PD-L1, programmed death-ligand
  1. [© 2019 Illustration Presentation ENDOCRINE SOCIETY].
papertitle: Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.
reftext: Lee-Shing Chang, et al. Endocr Rev. 2019 Feb;40(1):17-65.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9357876
figid_alias: PMC6270990__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6270990__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6270990__er.2018-00006f2.html
  '@type': Dataset
  description: Mechanisms of PD-1 action on T-cells. Engagement of PD-1 with its ligand
    PD-L1 induces an intracellular inhibitory pathway to inhibit costimulatory CD28-activated
    PI3K pathways. As a result, gluconeogenesis and glucose uptake decrease, leading
    to T-cell exhaustion. Bcl-xL, B-cell lymphoma-extra large; PD-L1, programmed death-ligand
    1. [© 2019 Illustration Presentation ENDOCRINE SOCIETY].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD28
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CD86
  - CD80
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - CD4
  - APC
  - PROC
---
